Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study.
Luca M M JanssenMickaël J C HiligsmannArianne Mathilda Josephus ElissenManuela A JooreNicolaas C SchaperJ H A BosmaCoen D A StehouwerS J S SepAnnemarie KosterMiranda T SchramSilvia M A A EversPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
This study showed that people with type 2 diabetes have substantially higher societal costs and lower quality of life than people with normal glucose tolerance. The results provide important input for future model-based economic evaluations and for policy decision-making.
Keyphrases